The cAMP response element-binding protein (CREB) has been shown to mediate transcriptional activation of genes in response to both cAMP and calcium influx signal transduction pathways. The roles of two multifunctional calcium/calmodulin-dependent protein kinases, CaMKIV and CaMKII, were examined in transient transfection studies that utilized either the full-length or the constitutively active forms of these kinases. The results indicate that CaMKIV is much more potent than CaMKII in activating CREB in three different cell lines.
Gonadotropin-releasing hormone (GnRH) interacts with a G protein-coupled receptor and increases the transcription of the glycoprotein hormone alpha-subunit gene. We have explored the possibility that mitogen-activated protein kinase (MAPK) plays a role in mediating GnRH effects on transcription. Activation of the MAPK cascade by an expression vector for a constitutively active form of the Raf-1 kinase led to stimulation of the alpha-subunit promoter in a concentration-dependent manner. GnRH treatment was found to increase the phosphorylation of tyrosine residues of MAPK and to increase MAPK activity, as determined by an immune complex kinase assay. A reporter gene assay using the MAPK-responsive, carboxy-terminal domain of the Elk1 transcription factor was also consistent with GnRH-induced activation of MAPK. Interference with the MAPK pathway by expression vectors for kinase-defective MAPKs or vectors encoding MAPK phosphatases reduced the transcription-stimulating effects of GnRH. The DNA sequences which are required for responses to GnRH include an Ets factor-binding site. An expression vector for a dominant negative form of Ets-2 was able to reduce GnRH effects on expression of the alpha-subunit gene. These findings provide evidence that GnRH treatment leads to activation of the MAPK cascade in gonadotropes and that activation of MAPK contributes to stimulation of the alpha-subunit promoter. It is likely that an Ets factor serves as a downstream transcriptional effector of MAPK in this system.
Recently, a pituitary-specific enhancer was identified within the 5' flanking region of The glycoprotein hormones are a family of heterodimeric proteins which consist of a common a subunit noncovalently associated with a hormone-specific 13 subunit (37). The glycoprotein hormones include the pituitary hormones, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone. In addition, some species also synthesize a chorionic gonadotropin within the placenta. Within a species, the glycoprotein hormones all share a common a subunit, while the unique ,B subunits specify the biological activity of the heterodimer. In the pituitary gland, luteinizing hormone and follicle-stimulating hormone are synthesized within cells which are designated gonadotropes, while thyroid-stimulating hormone is synthesized in thyrotropes. Thus, the glycoprotein hormone a-subunit gene is expressed within two different cell types in the pituitary and in some species within the placenta. The mechanisms mediating the tissue-specific expression of the a-subunit gene have been the focus of a large number of studies. While a number of DNA elements which are important for at-subunit expression in the placenta have been identified (3,4,11,12,25,28,34,46), much less is known concerning requirements for expression in the pituitary. It has been demonstrated that reporter genes containing various * Corresponding author. Mailing address:
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.